Hypertrophic cardiomyopathy: infants, children, and adolescents.
about
Beta-Blockers in Pediatric Hypertrophic CardiomyopathiesCardiomyopathies in childrenClinical Characteristics and Treatment of Cardiomyopathies in Children.Pediatric cardiomyopathies: causes, epidemiology, clinical course, preventive strategies and therapies.Increased Transforming Growth Factor-β Levels Associated With Cardiac Adverse Events in Hypertrophic Cardiomyopathy.
P2860
Hypertrophic cardiomyopathy: infants, children, and adolescents.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Hypertrophic cardiomyopathy: infants, children, and adolescents.
@ast
Hypertrophic cardiomyopathy: infants, children, and adolescents.
@en
Hypertrophic cardiomyopathy: infants, children, and adolescents.
@nl
type
label
Hypertrophic cardiomyopathy: infants, children, and adolescents.
@ast
Hypertrophic cardiomyopathy: infants, children, and adolescents.
@en
Hypertrophic cardiomyopathy: infants, children, and adolescents.
@nl
prefLabel
Hypertrophic cardiomyopathy: infants, children, and adolescents.
@ast
Hypertrophic cardiomyopathy: infants, children, and adolescents.
@en
Hypertrophic cardiomyopathy: infants, children, and adolescents.
@nl
P2860
P1476
Hypertrophic cardiomyopathy: infants, children, and adolescents.
@en
P2093
Shiraz A Maskatia
P2860
P356
10.1111/J.1747-0803.2011.00613.X
P577
2012-01-06T00:00:00Z